Go To Global Site
Welcome to UCB in the United States
Nov 23
Erica Puntel, U.S. Communications Lead - Neurology
New Digital Treatment Tracker for People Living with Epilepsy

At UCB, we are dedicated to breaking the barriers to better care by recognizing, understanding and empowering people living with epilepsy not only through diagnosis and treatment, but along every step in their healthcare journey. During Epilepsy Awareness Month, as part of our commitment to providing solutions that positively impact the lives of patients with neurological conditions, we enthusiastically announce a new initiative with Medisafe – the leading integrated medication management platform, personalized to engage patients and deliver outcomes.  

Our goal is to support patients in starting – and staying – on track with their treatment through the help of a user-friendly digital platform available to download as a free app. Patients who are currently using certain UCB medicines for the treatment of epilepsy can easily gain access to personalized patient support resources and timely interventions provided on the app, such as:

  • Information about financial support 
  • Disease and medication education for newly diagnosed patients as well as tools to support a patient’s journey
  • ucbCARES contact information for additional treatment management support 



The increase in digital health has led more patients to utilize digital tools for medication management, especially those who are battling a chronic condition like epilepsy.  Medisafe’s functionality combined with the resources and education sponsored by UCB provides an elevated level of support for patients. This digital health platform complements ongoing medication therapy to make living with epilepsy easier to manage, and easier to live with. 

“At UCB, we focus on developing resources that deliver a purposeful impact to people living with epilepsy. As part of our ongoing digitalization efforts, the Medisafe app will allow us to continue supporting patients with new, innovative ways of navigating their health,” said Anita Moser, Head of Assets and Optimization for U.S. Neurology, UCB. “The ability to support patients digitally is more important than ever, and we are pleased to deliver personalized and immediate assistance directly to epilepsy patients and their caregivers to help alleviate the gap in care exacerbated by the COVID crisis.”
As a company dedicated to deeply understanding people living with epilepsy, and surrounding patients at every step of their journey, we look forward to the impact this partnership will have on helping to build a better future for patients living with epilepsy.

Share:linkedin| twitter| email